SEC Form 4 · accession 0001587221-17-000027
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Greathouse
Director
Period of report
Oct 3, 2017
Accepted (ET)
Oct 5, 2017 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.84 | Oct 3, 2017 | A | 60,000 | A | — | Oct 3, 2027 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F125% of the total number of shares underlying the stock option vest on October 3, 2018, and the remaining underlying shares vest in equal monthly installments over the following three-year period.